ACAD · Acadia Pharmaceuticals Inc · Documents
$20.27
+0.08 (+0.40%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$3.51B
Shares
172.31M
Volume · Oct 22
200.26K
Avg daily vol (3M)
1.86M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-24 | — | |
| 8-K | — | 2026-09-11 | — | |
| Investor Event Transcript | — | 2026-08-12 | 2026-09-30 | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-08-04 | — | |
| 8-K | — | 2026-05-29 | — | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-12 | 2026-06-30 | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| 8-K | — | 2026-05-01 | 2026-04-27 | |
| DEF 14A | — | 2026-04-24 | 2026-05-29 | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| 8-K | — | 2026-03-05 | 2026-03-03 | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-02-25 | — | |
| 8-K | — | 2026-01-13 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-05 | — | |
| 8-K | — | 2025-11-03 | 2025-10-28 | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-06-10 | 2025-06-09 | |
| 8-K | — | 2025-05-29 | — | |
| 8-K | — | 2025-05-20 | 2025-05-15 | |
| S-3 | — | 2025-05-09 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| DEF 14A | — | 2025-04-25 | 2025-05-29 | |
| ARS | — | 2025-04-25 | 2024-12-31 | |
| 8-K | — | 2025-04-16 | 2025-04-15 | |
| 10-K | — | 2025-02-27 | 2024-12-31 | |
| 8-K | — | 2025-02-26 | — | |
| 8-K | — | 2024-12-11 | — | |
| 8-K | — | 2024-11-20 | 2024-11-18 | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-11-06 | — | |
| 8-K | — | 2024-09-23 | 2024-09-17 | |
| 10-Q | — | 2024-08-07 | 2024-06-30 | |
| 8-K | — | 2024-08-06 | — | |
| 8-K | — | 2024-05-29 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-08 | — | |
| DEF 14A | — | 2024-04-26 | 2024-05-29 | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| 8-K | — | 2024-03-11 | — | |
| 10-K | — | 2024-02-28 | 2023-12-31 | |
| 8-K | — | 2024-02-27 | — | |
| 8-K | — | 2024-01-31 | 2024-01-30 | |
| 8-K | — | 2023-11-21 | — |
Showing 1–50 of 113 filings
Key facts
CIK
1070494
CUSIP
004225108
13F (30d)
42 filings
41 filers
Visit website
Investor relations